BUILDING IN PUBLIC

The public changelog.

A dated record of the work. Publishing a strategy or adding a resource is a documentation update; product milestones remain at 0%.

Subscribe via Atom
Datasets & models library

OpenPharma RDKit fork created

Created a public code fork of rdkit/rdkit with the upstream BSD 3-Clause licence retained. This establishes a software starting point; no dataset mirror, benchmark result or completed product milestone is claimed.

View the published artifact ↗

Datasets & models library

OpenPharma DeepChem fork created

Created a public code fork of deepchem/deepchem with its upstream MIT licence retained. No OpenPharma model training, dataset mirroring or benchmark validation has been completed.

View the published artifact ↗

Drug discovery engine

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.

Clinical evidence automation

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.

Lab in a box

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.

Datasets & models library

Public learning and training resources catalogued

Added ten upstream datasets, software projects and a model checkpoint with access instructions and reuse notes. These are learning and research resources, not a locally validated training collection or a complete database mirror.

Datasets & models library

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.

Manufacturing cost reduction

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.

Drug repurposing engine

Phase 0–5 strategy and portal plan published

Published the module strategy, concrete phase deliverables, acceptance criteria and future portal workflow. This is a planning update; product completion remains 0%.